hCG Injection 5000 IU

hCG injection 5000IU
  • Dosage: Human Chorionic Gonadotropin (hCG) 5000 IU
  • Volume:  2 ml per  Vial 
  • Packaging: Sterile Ampoules for injection, 1 vial/tray+1 water for injection box
  • Shelf Life: 36months 

Click to add this item to cart.

Product Description

Product NameHuman Chorionic Gonadotropin (hCG) Injection (Lyophilized Powder for Injection)
Specification5000 IU per vial
Dosage FormSterile, Nonpyrogenic Lyophilized Powder for Injection (for intramuscular or subcutaneous injection after reconstitution)
Active IngredientHuman Chorionic Gonadotropin (hCG, glycoprotein hormone)
Pharmacological ClassGonadotropin / Luteinizing Hormone (LH) Agonist / Reproductive Hormone Preparation
Route of AdministrationIntramuscular (IM) or subcutaneous (SC) injection after reconstitution. NOT for intravenous administration.
Packaging5000 IU sterile type I glass vial (lyophilized powder) + 1 ampoule of Water for Injections (solvent, typically 1–2mL) per pack
StorageStore refrigerated at 2°C to 8°C, protected from light. Do not freeze. Keep vial and ampoule in outer carton until use. Reconstituted solution should be used immediately (within a few hours).
Shelf Life36 months (unopened, refrigerated)

Product Overview

Human Chorionic Gonadotropin (hCG) Injection 5000 IU is a sterile, nonpyrogenic, lyophilized powder intended for reconstitution with the provided Water for Injections and subsequent intramuscular or subcutaneous injection. Each vial contains 5000 IU of human chorionic gonadotropin. hCG is a glycoprotein hormone that is structurally and functionally similar to luteinizing hormone (LH), and exerts its biological effects by binding to LH/hCG receptors in the gonads. The product is supplied as a lyophilized powder in combination with a solvent ampoule for reconstitution.

hCG Injection 5000 IU: What the Published Guidance Says

The obstetric emergency medicines and newborn-care antiseptics that sit on the WHO Model List — supplied with the labelling discipline these products demand.

hCG Injection 5000 IU is specified against its own monograph, pack size and market registration, so the guidance below is worth reading together with the Maternal & Newborn range overview.

  • The protocol, and why presentation matters MSF describes two protocols: an intravenous/intramuscular schedule of 4 g by IV infusion over 15–20 minutes, then 10 g intramuscularly, then 5 g IM every four hours; and an IV-only schedule of 4 g over 15–20 minutes followed by 1 g per hour. Treatment continues for 24 hours after delivery or the last seizure. MSF Essential Drugs — Magnesium sulfate injectable
  • Monitoring and the antidote Patellar reflex, blood pressure, heart and respiratory rate are checked every 15 minutes during the first hour, then hourly, with urine output checked hourly. If signs of overdose appear, magnesium sulfate is stopped and 1 g calcium gluconate given by slow intravenous injection as the antidote. MSF also notes magnesium sulfate should not be combined with nifedipine. MSF Essential Drugs — Magnesium sulfate injectable
  • MSF's own warning: check the ampoule strength Because magnesium sulfate is supplied in several strengths, MSF explicitly instructs users to check the strength of the ampoule carefully before use, noting that 1 g ampoules exist alongside the 5 g presentation it describes. MSF Essential Drugs — Magnesium sulfate injectable

We quote these sources rather than paraphrase them loosely, because the detail matters commercially for hCG Injection 5000 IU. Where your national list differs from the WHO listing, the national list governs what may be supplied and promoted locally.

Supply & Specification Data for hCG Injection 5000 IU

Product NameHuman Chorionic Gonadotropin (hCG) Injection (Lyophilized Powder for Injection)
Specification5000 IU per vial
Dosage FormSterile, Nonpyrogenic Lyophilized Powder for Injection (for intramuscular or subcutaneous injection after reconstitution)
Active IngredientHuman Chorionic Gonadotropin (hCG, glycoprotein hormone)
Pharmacological ClassGonadotropin / Luteinizing Hormone (LH) Agonist / Reproductive Hormone Preparation
Route of AdministrationIntramuscular (IM) or subcutaneous (SC) injection after reconstitution. NOT for intravenous administration.
StorageStore refrigerated at 2°C to 8°C, protected from light. Do not freeze. Keep vial and ampoule in outer carton until use. Reconstituted solution should be used immediately (within a few hours).
Therapeutic groupMaternal & Newborn — Maternal & Newborn
ManufacturerSinophare Bio-technology Co., Ltd. (GMP, China)
Documentation suppliedCOA, HPLC/GC data, stability data, dossier package

The same therapeutic range is supplied in several presentations, so one purchase order can cover a mixed requirement: Magnesium Sulphate BP 10% 10mL, Metronidazole Suppository 500mg, Chlorhexidine Acetate Suppository 20mg, Erythromycin Suppositories 100mg, Martrine Suppository 50mg, Progesterone Suppository 25mg, Clotrimazole Vaginal Suppositories 150mg.

Testing, Monographs & Batch Documentation

Products are manufactured and tested against USP, EP, BP and CP monographs, with incoming raw-material inspection, in-process monitoring and full finished-product testing.

Every batch of hCG Injection 5000 IU is tested to the monograph stated on the purchase order. Where a monograph is silent on the presentation, we agree a written specification with you in advance and reference it on the certificate of analysis.

Standardised GMP production workshops with an independent R&D laboratory and a complete quality-inspection centre.

The batch record for this product normally includes:

  • Testing for water content and pH where applicable
  • Testing for sterility and bacterial endotoxins (parenterals and ophthalmics)
  • Testing for microbial limits and preservative efficacy (multi-dose presentations)
  • Testing for heavy metals and elemental impurities
  • Testing for packaging integrity and seal testing
  • Testing for description and identification

COA, HPLC and GC data, DMF and dossier packages, plus registration support documents for national marketing-authorisation filings.

Pack Configuration, Artwork & Shipping Documents

  • Pack size: 5000 IU sterile type I glass vial (lyophilized powder) + 1 ampoule of Water for Injections (solvent, typically 1–2mL) per pack. Non-standard pack sizes can be quoted against your artwork.
  • Storage: Store refrigerated at 2°C to 8°C, protected from light. Do not freeze. Keep vial and ampoule in outer carton until use. Reconstituted solution should be used immediately (within a few hours)..
  • Shelf life: 36 months (unopened, refrigerated). Stability data for the marketed pack is included in the dossier.
  • Labelling: we typeset the carton and leaflet in English, Arabic, French, Russian and Spanish and in any further language your market requires, carrying your own brand where the local rules allow.
  • Export: commercial invoice, packing list, certificate of origin, GMP certificate, COA and the free-sale certificate issued by the country of manufacture whenever your customs or regulator asks for it.

Dossier, Authority Filings & Tender Documentation

Documents for hCG Injection 5000 IU are issued by Sinophare Bio-technology Co., Ltd. — DML Number Jin20160068 (medicines) and Jin20160069 (paracetamol API).. Keeping one legal manufacturer across the COA, the GMP certificate and the registration file avoids assessment queries later.

  • Artwork and mock-up approval pack, showing the carton, label and leaflet exactly as they will be printed for your market.
  • Batch manufacturing and packaging records released for inspection on request during supplier audits.
  • Re-test or renewal support when the marketing authorisation comes up for variation or renewal.
  • CTD dossier modules 1–5 in editable and PDF form, with the finished-product and API sections cross-referenced.
  • Site Master File and GMP certificate for the manufacturing workshops.

The context for hCG Injection 5000 IU is its place among obstetric and newborn-care medicines named in the WHO Model List. Listing status informs how programmes specify a product; it is not a substitute for the import licence or marketing authorisation of the destination country.

Buyer Questions about hCG Injection 5000 IU

What pack size is available for hCG Injection 5000 IU?

This presentation is normally supplied as 5000 IU sterile type I glass vial (lyophilized powder) + 1 ampoule of Water for Injections (solvent, typically 1–2mL) per pack. Where your market requires a different count, bottle or carton, we quote to your artwork and extend the stability file to the new pack.

What documentation comes with a shipment of hCG Injection 5000 IU?

Shipments are accompanied by a certificate of analysis covering identification, assay and related substances, together with the marketed-pack stability data and the manufacturing site GMP certificate. Shelf life: 36 months.

Does the batch documentation for hCG Injection 5000 IU support a registration filing?

Shipments are accompanied by a certificate of analysis covering identification, assay and related substances, together with the marketed-pack stability data and the manufacturing site GMP certificate. Shelf life: 36 months. The full CTD dossier and the authority assessment file are supplied as part of a registration order; routine shipments carry the COA and stability data only.

Can you supply chlorhexidine for umbilical cord care?

Yes — chlorhexidine 7.1% digluconate delivering 4% chlorhexidine, the concentration and indication carried in section 22.7 of the WHO Model List.

Why do you emphasise single-dose chlorhexidine packaging?

MSF prefers the 3 g single-dose presentation over the 20 g tube to reduce the contamination risk associated with opened tubes.

Other Maternal & Newborn Products in This Range

Browse the full Maternal & Newborn range; all Injectables; the complete product catalogue.

Request a Quotation for hCG Injection 5000 IU

For tenders and programme supply, send the line item, pack size, quantity and destination for hCG Injection 5000 IU 5000IU. We return a quotation with lead time, documentation list and sample availability in one response.

Request a quotation

Sources & Regulatory Notes

Reference information only. The published guidance summarised on this page is quoted for professional and regulatory-context purposes and does not constitute medical advice, a prescribing recommendation or a promotion of any product for a particular indication. Prescribing decisions must follow the approved product information and national treatment guidelines in the market of use.

<< return to products